ACAMPROSATE CA 333MG TAB NATIONAL CMOP
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL CMOP OFFICE (36C770)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C77026Q0092
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents3
The Department of Veterans Affairs, through its National Consolidated Mail Outpatient Pharmacy (CMOP) Office, has issued Solicitation 36C77026Q0092 for the procurement of Acamprosate Calcium 333mg tablets. This solicitation seeks to establish a supply arrangement for the specified pharmaceutical product, supporting the ongoing needs of the VA’s national CMOP program, which plays a critical role in ensuring timely and reliable medication delivery to veterans across the United States.
The scope of this procurement encompasses the manufacturing and supply of Acamprosate Calcium 333mg tablets, classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505 (Drugs and Biologicals). The solicitation includes an attached pricing excel spreadsheet for offerors to provide detailed cost proposals, as well as the required Trade Agreements Certificate (FAR 52.225-6), indicating compliance with applicable trade regulations.
This opportunity is not set aside for any specific business category, meaning it is open to all qualified vendors without restrictions related to small business status or other socioeconomic designations. The place of performance is within the United States, aligning with the VA’s commitment to sourcing pharmaceuticals for domestic distribution through its federal supply chain.
The contracting activity is managed by the National CMOP Office (organization key 100183245), a federal office within the Department of Veterans Affairs. The primary point of contact for this solicitation is Sarah Fry, who can be reached at [email protected] or by phone at 913-758-9935 for any inquiries related to the procurement process or solicitation requirements.
Interested contractors should note that the solicitation is currently marked as inactive, with a posting date of March 17, 2026, and a response deadline of April 3, 2026. All relevant solicitation documents, including attachments, are available through the official SAM.gov opportunity listing (Opportunity ID: 1e0af01378de41c291df0bb929a886ba).
Contractors evaluating this opportunity should ensure they have the capability to manufacture and supply pharmaceutical preparations in accordance with federal requirements and are able to comply with all terms outlined in the solicitation and its attachments. The procurement is intended to support the VA’s mission of providing high-quality pharmaceutical care to veterans nationwide, and successful offerors will be expected to deliver consistent, compliant, and timely product as specified.